Brief: Progenity Provides Corporate Update And Reports Fourth Quarter Loss Per Share Of $0.56
March 28 (Reuters) - Progenity Inc PROG.O :
* PROGENITY PROVIDES CORPORATE UPDATE AND REPORTS FOURTH
QUARTER
AND FULL YEAR 2021 FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.56
* GENERATED $7.7 MILLION IN REVENUES DURING Q4, OUT OF WHICH
$7.2
MILLION CAME FROM DISCONTINUED OPERATIONS
Source text for Eikon: ID:nGNX9Hjy4l
Further company coverage: PROG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules